ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,117.52
0.34%
US Tech 100
17,302.40
0.36%
Dow Jones
38,354.83
0.30%
Brent Oil
87.65
-0.03%
Bitcoin
62,899.01
-0.16%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Diaceutics Plc (DXRX) Quote

Diaceutics Plc

Diaceutics Plc (DXRX)

LSE
103.00
0.00
(0.00%)
Closed April 29 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
103.00
Bid
102.00
Ask
104.00
Volume
1,625
103.00 Day's Range 103.00
80.50 52 Week Range 109.00
Market Cap
87.007M
Previous Close
103.00
Open
103.00
Last Trade
1
@
103
(UT)
Last Trade Time
Financial Volume
1,674p
VWAP
103.00
Average Volume (3m)
58,437
Shares Outstanding
84,472,431
Dividend Yield
-
PE Ratio
119.77
Earnings Per Share (EPS)
0.01
Revenue
19.5M
Net Profit
724k

About Diaceutics Plc

Sector
Testing Laboratories
Industry
Testing Laboratories
Website
www.diaceutics.com
Headquarters
Belfast, Irl
Founded
1970
Diaceutics Plc is listed in the Testing Laboratories sector of the London Stock Exchange with ticker DXRX. The last closing price for Diaceutics was 103p. Over the last year, Diaceutics shares have traded in a share price range of 80.50p to 109.00p.

Diaceutics currently has 84,472,431 shares outstanding. The market capitalization of Diaceutics is £87.01 million. Diaceutics has a price to earnings ratio (PE ratio) of 119.77.

DXRX Latest News

More News

Diaceutics PLC Appointment of Amie Mc Neice as VP of Marketing

Diaceutics PLC 09 April 2024   Diaceutics appoints Amie Mc Neice as VP of Marketing   Belfast and London, 9 April 2024 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider...

April 09 2024
RNS Regulatory News

Diaceutics PLC Block Listing Return

Diaceutics PLC 05 April 2024     Diaceutics PLC   BLOCK LISTING RETURN     Belfast and London, 5 April 2024 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the...

April 05 2024
RNS Regulatory News

Diaceutics PLC PDMR Shareholding/Share Incentive Plan

Diaceutics PLC 03 April 2024     Diaceutics PLC   PDMR Shareholding/Share Incentive Plan   Belfast and London, 3 April 2024 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions...

April 03 2024
RNS Regulatory News

TRADING UPDATES: Roadside shares suspended; Adnams looks for funds

The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by A ...

April 02 2024
Alliance News

Diaceutics PLC Director/PDMR/PCA Shareholding & TR1

Diaceutics PLC 02 April 2024    Director / PDMR / PCA Shareholding & TR-1 Notification   Belfast and London, 2 April 2024 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions...

April 02 2024
RNS Regulatory News

Diaceutics upgrades diagnositc commercialisation platform, DXRX

Diaceutics PLC on Thursday said it has launched a "significant upgrade" to its DXRX platform. Shares in Diaceutics ...

March 21 2024
Alliance News

Diaceutics PLC Significant upgrade to Diaceutics' DXRX platform

Diaceutics PLC 21 March 2024   Reach Diaceutics launches significant upgrade to its DXRX platform New functionality will involve a best in class combination of generative AI and integrated...

March 21 2024
RNS Non-Regulatory

Diaceutics PLC Diaceutics forms landmark industry Forum

Diaceutics PLC 19 March 2024   RNS Reach   Diaceutics PLC   Diaceutics forms landmark industry Forum to address the economic barriers preventing patient access to life-changing precision...

March 19 2024
RNS Non-Regulatory

Diaceutics PLC Director/PDMR Shareholding

Diaceutics PLC 07 March 2024   Diaceutics PLC   Director / PDMR Shareholding - NED Purchase of Shares     Belfast and London, 07 March 2024 - Diaceutics PLC (AIM: DXRX), a leading technology...

March 07 2024
RNS Regulatory News

Diaceutics PLC PDMR Shareholding / SIP and TVR

Diaceutics PLC 01 March 2024     1 March 2024 Diaceutics PLC   PDMR Shareholding/Share Incentive Plan and Total Voting Rights   Diaceutics PLC, (AIM: DXRX), a leading technology and solutions...

March 01 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10010310410323735103.03074836DE
4-1-0.96153846153810410510374566103.82470881DE
1266.185567010319710793.558437101.04629512DE
2619.523.353293413283.510783.55340596.21871646DE
523310010980.55348595.26813716DE
156-22.5-17.9282868526125.5130.574.559008103.54613824DE
2601213.18681318689119174.551764112.42746798DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CAUDCollective Audience Inc
$ 0.7912
(102.87%)
130.75M
DCPHDeciphera Pharmaceuticals Inc
$ 25.21
(72.08%)
38.48M
SINTSiNtx Technologies Inc
$ 0.0559
(38.37%)
127.46M
HWHHWH International Inc
$ 2.5102
(37.92%)
21.87M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 9.5912
(34.14%)
57.02M
CLVRClever Leaves Holdings Inc
$ 1.61
(-60.83%)
593.93k
ADXNAddex Therapeutics Ltd
$ 8.50
(-47.20%)
115.44k
TSDDGraniteShares ETF Trust GraniteShares
$ 16.4565
(-33.91%)
987.18k
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 25.9955
(-33.80%)
5.04M
MFImF International Ltd
$ 1.64
(-29.61%)
2.29M
TSLATesla Inc
$ 196.915
(17.01%)
143.16M
CAUDCollective Audience Inc
$ 0.7912
(102.87%)
130.76M
SINTSiNtx Technologies Inc
$ 0.0559
(38.37%)
127.46M
SOFISoFi Technologies Inc
$ 7.0982
(-9.81%)
108.54M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 9.5912
(34.14%)
57.02M

Discussion

View Full Feed
SSKILLZ1 SSKILLZ1 11 seconds ago
My Take on Last Night's Show

The top 10 performed last night at the end they cut it to 8. before a further cut tomorrow after another round of performances. Here goes.

1) Mia- Singing a ST song. It was pitchey mess for me. Well below average. Worst performance of the ni
diggitydoodle diggitydoodle 13 seconds ago
Buys are low. This ticker has potential and a super low pps. It's gonna need consecutive days or a week or two of billions of volume.
Share structure sucks.
RNVA!!$$$$$$????????????????
RNVA
jcromeenes jcromeenes 17 seconds ago
I heard he's also way out in front to be the cell block leader at Rykers!
FNMA
Bubae Bubae 18 seconds ago
No one cares if you have someone on ignore. Lease of all me. My posts are for those conducting their own due diligence on this. You all represent old money. What these toxic note holders need is new money and a lot of it.
BEGI
JALchicago JALchicago 41 seconds ago
Writes an opinion talking about how he can’t understand how people bash others with opinions but starts off by calling people with opinions different than his low life’s.

Can’t make this up.
ACRL
resx18 resx18 43 seconds ago
I wonder how the show is going? $CBDW
CBDW
Arti3boy Arti3boy 44 seconds ago
You can convert them now, I talked to E*trade on Friday, they will convert mine for 300
NSAV
ChannelTrader ChannelTrader 52 seconds ago
Yeah ~
No, the government is not to be trusted
thewolfoftrade thewolfoftrade 54 seconds ago
Wy
BCAP
Kool Aid Man Kool Aid Man 59 seconds ago
Every filling, PR, website and even OTC uses Strickland's Florida phone number. He's clearly not gone
SPZI
stock1ace1 stock1ace1 1 minute ago
IMAB $1.82 *** bb is super tight
IMAB
resx18 resx18 1 minute ago
Looking good here .. $CBDW
CBDW
B_B! B_B! 1 minute ago
Only 5 weeks left 😰
PLUG
wisetoit wisetoit 1 minute ago
Yes, you can short this at .0001 there are 257 million shares available according to the broker I called.
PSRU
Smartypants2 Smartypants2 1 minute ago
Maybe XERI has more important things to do that constantly updating their website every time NNC makes another change that may or may not impact their bottom line.
XERI
Monksdream Monksdream 1 minute ago
TCON under $2
https://investorshub.advfn.com/uimage/uploads/2024/4/29/wnmtqIMG_7832.gif
TCON
buddynika buddynika 2 minutes ago
Thanks, They just saw it my way and cleared me.
EBET
PennyHoper PennyHoper 2 minutes ago
[hand-deleted post]
infamous infamous 2 minutes ago
what price?
EBET
getmoreshares getmoreshares 2 minutes ago
thank you
BCAP
georgie18 georgie18 2 minutes ago
CAUD...74...🥳...Was looking for Break/Hold of .98...Barely holding the 50ma right now...
CAUD
DewDiligence DewDiligence 2 minutes ago
ANVS -58% on purportedly-positive phase-2/3 data in AD:

https://www.globenewswire.com/news-release/2024/04/29/2871378/0/en/Annovis-Bio-Announces-Statistically-Significant-Phase-II-III-Data-in-Patients-With-Early-Alzheimer-s-Disease.html This study was designed to enroll 80 patients p
ANVS
jedijazz jedijazz 2 minutes ago
$PNPNF - Facing a (20X) Surge in Demand, This Hidden Gem Could be Sitting on a Potential Billion-Dollar Nickel Deposit
https://reports.stocknewstrends.com/facing-a-20x-surge-in-demand-this-hidden-gem-could-be-sitting-on-a-potential-billion-dollar-nickel-deposit?utm_source=corporateads&utm_med
PNPNF
jedijazz jedijazz 2 minutes ago
$PNPNF - Facing a (20X) Surge in Demand, This Hidden Gem Could be Sitting on a Potential Billion-Dollar Nickel Deposit
https://reports.stocknewstrends.com/facing-a-20x-surge-in-demand-this-hidden-gem-could-be-sitting-on-a-potential-billion-dollar-nickel-deposit?utm_source=corporateads&utm_med
PNPNF
Gary Ray Gary Ray 2 minutes ago
If by calling you out as well as BITF makes me an idiot then so be it.
Check out the SP now :)
BITF

Your Recent History

LSE
DXRX
Diaceutics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved